Market Tracker

10/24 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.51
Data as of Oct 24
 +0.04 / +2.72%
Today’s Change
1.16
Today|||52-Week Range
3.18
+8.63%
Year-to-Date

Today’s Trading

Previous close1.47
Today’s open1.48
Day’s range1.46 - 1.53
Volume885,218
Average volume (3 months)1,067,813
Market cap$263.9M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-37.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.03+1.08%
CCXIChemoCentryx Inc-0.23-3.87%
POZNPOZEN Inc0.000.00%
AMBIAmbit Biosciences Co...-0.07-0.45%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateDecember 11, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts